Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedJun 11, 2026
DataAggregated Company Financials
Companies9
- 7D1.9%
- 3M8.7%
- 1Y21.1%
- YTDn/a
The Pharma industry is up 1.9% in the last week, with Bayer up 0.6%. This means that the industry has gained 21% over the past year. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 12 Jun 2026 | €96.8b | €67.4b | €482.5m | 23.4x | 200.7x | 1.4x |
| Sun, 10 May 2026 | €88.4b | €67.9b | -€888,696,183.51 | 18x | -99.4x | 1.3x |
| Tue, 07 Apr 2026 | €89.9b | €67.9b | -€900,262,286.16 | 20.1x | -99.9x | 1.3x |
| Thu, 05 Mar 2026 | €93.4b | €68.3b | €2.9b | 18x | 32.6x | 1.4x |
| Sat, 31 Jan 2026 | €101.1b | €68.3b | €2.9b | 17.3x | 35.3x | 1.5x |
| Mon, 29 Dec 2025 | €90.6b | €68.3b | €2.9b | 17.8x | 31.6x | 1.3x |
| Wed, 26 Nov 2025 | €83.5b | €68.5b | €2.9b | 17x | 29x | 1.2x |
| Fri, 24 Oct 2025 | €80.2b | €68.8b | -€439,059,476.45 | 19.2x | -182.7x | 1.2x |
| Sun, 21 Sep 2025 | €77.1b | €68.8b | -€438,183,950.69 | 17.3x | -175.9x | 1.1x |
| Tue, 19 Aug 2025 | €78.5b | €68.9b | -€409,991,404.97 | 17.2x | -191.3x | 1.1x |
| Thu, 17 Jul 2025 | €77.6b | €69.4b | -€283,071,598.00 | 17.5x | -274x | 1.1x |
| Sat, 14 Jun 2025 | €79.4b | €69.4b | -€206,268,848.00 | 18x | -385.1x | 1.1x |
| Mon, 12 May 2025 | €80.0b | €69.3b | €463.8m | 19x | 172.5x | 1.2x |
| Wed, 09 Apr 2025 | €73.0b | €69.3b | €467.0m | 17.6x | 156.3x | 1.1x |
| Fri, 07 Mar 2025 | €88.5b | €69.2b | €436.0m | 22.1x | 203.1x | 1.3x |
| Sun, 02 Feb 2025 | €87.7b | €69.2b | €2.0b | 23.6x | 43.2x | 1.3x |
| Tue, 31 Dec 2024 | €82.5b | €69.2b | €2.0b | 22.6x | 41.1x | 1.2x |
| Thu, 28 Nov 2024 | €83.1b | €69.2b | €2.0b | 22x | 41.1x | 1.2x |
| Sat, 26 Oct 2024 | €95.5b | €69.4b | €1.6b | 20.3x | 61.2x | 1.4x |
| Mon, 23 Sep 2024 | €99.3b | €69.4b | €1.5b | 24x | 68x | 1.4x |
| Wed, 21 Aug 2024 | €104.3b | €69.3b | €1.5b | 31.1x | 71.6x | 1.5x |
| Fri, 19 Jul 2024 | €95.3b | €69.2b | -€303,627,757.00 | 29.2x | -314x | 1.4x |
| Sun, 16 Jun 2024 | €103.9b | €69.2b | -€328,028,608.00 | 22.6x | -316.8x | 1.5x |
| Tue, 14 May 2024 | €98.6b | €70.0b | -€71,350,159.70 | 20.2x | -1381.7x | 1.4x |
| Thu, 11 Apr 2024 | €94.8b | €70.0b | -€34,208,180.00 | 20.7x | -2772.2x | 1.4x |
| Sat, 09 Mar 2024 | €96.7b | €70.0b | €6.2m | 20x | 15603.9x | 1.4x |
| Mon, 05 Feb 2024 | €94.9b | €70.6b | -€647,396,793.00 | 22.1x | -146.6x | 1.3x |
| Wed, 03 Jan 2024 | €98.5b | €70.6b | -€650,504,143.00 | 19.7x | -151.5x | 1.4x |
| Fri, 01 Dec 2023 | €103.1b | €70.6b | -€650,606,256.00 | 19x | -158.5x | 1.5x |
| Sun, 29 Oct 2023 | €104.5b | €72.1b | €4.7b | 17.6x | 22.3x | 1.4x |
| Tue, 26 Sep 2023 | €116.9b | €72.1b | €4.7b | 22x | 25x | 1.6x |
| Thu, 24 Aug 2023 | €122.5b | €72.1b | €4.7b | 22.7x | 26.2x | 1.7x |
| Sat, 22 Jul 2023 | €121.5b | €74.1b | €6.5b | 18.8x | 18.8x | 1.6x |
| Mon, 19 Jun 2023 | €126.9b | €74.1b | €6.4b | 22.3x | 19.8x | 1.7x |
Price to Earnings Ratio
19.8x
Current Industry PE
- Investors are optimistic on the German Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 201x which is higher than its 3-year average PE of 129x.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 58% per year over the last three years,
- Revenues have also declined 3.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Comparison
How does German Pharma compare with similar industries?
| DE Market | -2.62% | |
| Healthcare | 2.29% | |
| Pharma | 1.93% | |
| Pharma | 1.93% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BAYN Bayer | €35.79 | 0.6% +€226.0m | 28.6% | PS0.8x | |
| DMP Dermapharm Holding | €47.95 | 1.1% +€24.8m | 34.5% | PE16.5x | |
| 93M1 MPH Health Care | €27.20 | 5.0% +€5.6m | 38.4% | PS2.3x |